The Mato Grosso do Sul Association for Research and Support for Medicinal Cannabis – Divina Flor has obtained a judicial safe-conduct authorizing the planting, cultivation, and distribution of cannabis oils and extracts. The decision by the Federal Regional Court of the 3rd Region (TRF3) is valid until September 30 and exclusively benefits associated patients who can prove medical need.

The deadline until September was established due to the Action Plan for Regulation and Inspection, endorsed by the Federal Government. The date corresponds to the deadline for the publication of regulations on the cultivation of cannabis for medicinal purposes.

This plan establishes specific rules for five production models currently existing in the country. Among them is the associative regime, followed by Divina Flor. According to the National Overview of Cannabis Associations, published in July 2025, approximately 130.7 thousand people are currently under associative treatment.

Association Profile

The Divina Flor is an association for cannabis research and support, founded in 2020. Currently, it serves over 1,700 patients, including humans and animals, and has a team of 15 employees.

“In addition to providing more affordable medication to associated patients, our focus is also on the social work of providing treatment access to the low-income population,” a section of its website states.

Rules for Patients

With the safe-conduct, the association will be able to cultivate the plant, extract the oil, and distribute it only within its headquarters in Mato Grosso do Sul. To access treatment, patients must present an updated medical report every six months and meet requirements such as:

Registration on the LEGACY platform (with data protection);

Personal documents and proof of residence;

Adhesion term with legal responsibility;

Valid medical prescription indicating the use of cannabis.